BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16438098)

  • 61. Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic.
    Jandorf L; Gutierrez Y; Lopez J; Christie J; Itzkowitz SH
    J Urban Health; 2005 Jun; 82(2):216-24. PubMed ID: 15888638
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Factors associated with screening for colorectal cancer in a population-based sample.
    Stamatakis KA; Simoes EJ; Brownson RC; Vradenburg J; Murayi T
    Mo Med; 2002 Jul; 99(7):279-85. PubMed ID: 12198998
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
    Stock C; Ihle P; Schubert I; Brenner H
    Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research.
    Vernon SW; Meissner H; Klabunde C; Rimer BK; Ahnen DJ; Bastani R; Mandelson MT; Nadel MR; Sheinfeld-Gorin S; Zapka J
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):898-905. PubMed ID: 15184243
    [No Abstract]   [Full Text] [Related]  

  • 65. Knowledge of colon cancer screening in a national probability sample in the United States.
    Ford JS; Coups EJ; Hay JL
    J Health Commun; 2006; 11 Suppl 1():19-35. PubMed ID: 16641072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Market for colorectal cancer screening by endoscopy in the United States.
    Tangka FK; Molinari NA; Chattopadhyay SK; Seeff LC
    Am J Prev Med; 2005 Jul; 29(1):54-60. PubMed ID: 15958253
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases.
    Bastani R; Glenn BA; Maxwell AE; Ganz PA; Mojica CM; Chang LC
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):791-8. PubMed ID: 18381469
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vital signs: Colorectal cancer screening, incidence, and mortality--United States, 2002-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):884-9. PubMed ID: 21734636
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
    Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
    Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour.
    Zarychanski R; Chen Y; Bernstein CN; Hébert PC
    CMAJ; 2007 Sep; 177(6):593-7. PubMed ID: 17846441
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk and reluctance: understanding impediments to colorectal cancer screening.
    Weitzman ER; Zapka J; Estabrook B; Goins KV
    Prev Med; 2001 Jun; 32(6):502-13. PubMed ID: 11394954
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study.
    Mulder SA; van Soest EM; Dieleman JP; van Rossum LG; Ouwendijk RJ; van Leerdam ME; Kuipers EJ
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):437-43. PubMed ID: 19952765
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Screening for colorectal cancer: the business case.
    Fletcher RH; Colditz GA; Pawlson LG; Richman H; Rosenthal D; Salber PR
    Am J Manag Care; 2002 Jun; 8(6):531-8. PubMed ID: 12068960
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Test-retest reliability of colorectal testing questions on the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS).
    Bradbury BD; Brooks DR; Brawarsky P; Mucci LA
    Prev Med; 2005 Jul; 41(1):303-11. PubMed ID: 15917026
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Trends in colonoscopy for colorectal cancer screening.
    Phillips KA; Liang SY; Ladabaum U; Haas J; Kerlikowske K; Lieberman D; Hiatt R; Nagamine M; Van Bebber SL
    Med Care; 2007 Feb; 45(2):160-7. PubMed ID: 17224779
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary care patients' understanding of colorectal cancer screening.
    Greisinger A; Hawley ST; Bettencourt JL; Perz CA; Vernon SW
    Cancer Detect Prev; 2006; 30(1):67-74. PubMed ID: 16458449
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of the Danish national strategy for selective use of colonoscopy in symptomatic outpatients without known risk factors for colorectal cancer.
    Bjerregaard NC; Tøttrup A; Sørensen HT; Laurberg S
    Scand J Gastroenterol; 2007 Feb; 42(2):228-36. PubMed ID: 17327943
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparing risks and benefits of colorectal cancer screening in elderly patients.
    Ko CW; Sonnenberg A
    Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.